DK0844869T3 - ULMWH (heparin med ultralav molekylvægt) til behandling af astma - Google Patents
ULMWH (heparin med ultralav molekylvægt) til behandling af astmaInfo
- Publication number
- DK0844869T3 DK0844869T3 DK96926952T DK96926952T DK0844869T3 DK 0844869 T3 DK0844869 T3 DK 0844869T3 DK 96926952 T DK96926952 T DK 96926952T DK 96926952 T DK96926952 T DK 96926952T DK 0844869 T3 DK0844869 T3 DK 0844869T3
- Authority
- DK
- Denmark
- Prior art keywords
- ulmwh
- asthma
- treatment
- molecular weight
- low molecular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/516,786 US5690910A (en) | 1995-08-18 | 1995-08-18 | Method for treating asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0844869T3 true DK0844869T3 (da) | 2005-12-12 |
Family
ID=24057086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96926952T DK0844869T3 (da) | 1995-08-18 | 1996-08-13 | ULMWH (heparin med ultralav molekylvægt) til behandling af astma |
Country Status (22)
Country | Link |
---|---|
US (1) | US5690910A (fr) |
EP (1) | EP0844869B1 (fr) |
JP (1) | JP3263723B2 (fr) |
KR (1) | KR100451901B1 (fr) |
AR (1) | AR003271A1 (fr) |
AT (1) | ATE300938T1 (fr) |
AU (1) | AU701691B2 (fr) |
CA (1) | CA2229060A1 (fr) |
CZ (1) | CZ292134B6 (fr) |
DE (1) | DE69635023T2 (fr) |
DK (1) | DK0844869T3 (fr) |
ES (1) | ES2244974T3 (fr) |
HK (1) | HK1007060A1 (fr) |
HU (1) | HUP9901614A3 (fr) |
IL (1) | IL123166A (fr) |
NZ (2) | NZ315275A (fr) |
PL (1) | PL186912B1 (fr) |
PT (1) | PT844869E (fr) |
SK (1) | SK282759B6 (fr) |
UA (1) | UA62919C2 (fr) |
WO (1) | WO1997006783A1 (fr) |
ZA (1) | ZA966838B (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980865A (en) * | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
SI1124563T1 (en) * | 1998-10-30 | 2005-02-28 | Ivax Research, Inc. | Methods and compositions for the prevention of tolerance to bronchodilators |
US6235725B1 (en) * | 1998-10-30 | 2001-05-22 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for the prevention of tolerance to medications |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
ES2527853T3 (es) | 2000-03-08 | 2015-01-30 | Massachusetts Institute Of Technology | Heparinasa III y sus usos |
EP1292314A2 (fr) * | 2000-05-23 | 2003-03-19 | The Trustees of Columbia University in the City of New York | Procede de traitement des troubles respiratoires associes a une lesion de la fibre elastique pulmonaire |
US7083937B2 (en) | 2000-09-12 | 2006-08-01 | Massachusetts Institute Of Technology | Methods and products related to the analysis of polysaccarides |
CA2423469A1 (fr) * | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Procedes et produits associes a l'administration pulmonaires de polysaccharides |
ES2425392T3 (es) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartucho para un aparato de inhalación |
US20040171819A1 (en) | 2002-10-10 | 2004-09-02 | Aventis Pharma S.A. | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
PL1791542T3 (pl) | 2004-08-23 | 2015-11-30 | Mannkind Corp | Sole diketopiperazyny do dostarczania leków |
AU2005282065B2 (en) * | 2004-09-10 | 2013-02-07 | Pharmaorigin Aps | Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis |
AU2006290870B2 (en) | 2005-09-14 | 2013-02-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
EP2497484A3 (fr) | 2006-02-22 | 2012-11-07 | MannKind Corporation | Procédé pour améliorer les propriétés pharmaceutiques de microparticules comprenant de la dicétopipérazine et un agent actif |
US8592393B2 (en) | 2007-11-02 | 2013-11-26 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
EP2205642B1 (fr) * | 2007-11-02 | 2016-01-27 | Momenta Pharmaceuticals, Inc. | Compositions de polysaccharides non anticoagulants |
US8569262B2 (en) * | 2007-11-02 | 2013-10-29 | Momenta Pharmaceuticals, Inc. | Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
DK2570147T3 (da) | 2008-06-13 | 2018-01-29 | Mannkind Corp | Tørpulverinhalator og system til lægemiddelindgivelse |
KR101628410B1 (ko) | 2008-06-20 | 2016-06-08 | 맨카인드 코포레이션 | 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법 |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2754595C (fr) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Appareil, systeme et procede de mesure de resistance d'un inhalateur |
US8734845B2 (en) | 2009-06-12 | 2014-05-27 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
CA2778698A1 (fr) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | Appareil et methode de simulation d'efforts d'inhalation |
CA2781923C (fr) * | 2009-12-03 | 2018-08-14 | Opko Health, Inc. | Formulations de disaccharides hypersulfates |
WO2011130697A2 (fr) | 2010-04-16 | 2011-10-20 | Momenta Pharmaceuticals, Inc. | Ciblage tissulaire |
CN103096870B (zh) | 2010-06-17 | 2017-04-19 | 动量制药公司 | 调节毛发生长的方法和组合物 |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
RU2528093C2 (ru) * | 2010-07-21 | 2014-09-10 | Олег Ильич Эпштейн | Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля |
JP2014500863A (ja) * | 2010-10-29 | 2014-01-16 | オプコ ヘルス インコーポレイテッド | エラスターゼ関連障害を治療するための高硫酸化二糖 |
MY180552A (en) | 2011-04-01 | 2020-12-02 | Mannkind Corp | Blister package for pharmaceutical cartridges |
WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
WO2013063160A1 (fr) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Procédés et compositions pour traiter la douleur |
CA2878457C (fr) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Systemes et procedes de liberation de medicament en poudre seche |
WO2014066856A1 (fr) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Compositions et procédés de vaccin antigrippal inhalable |
BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
CA2910837A1 (fr) | 2013-05-28 | 2014-12-04 | Momenta Pharmaceuticals, Inc. | Compositions pharmaceutiques |
CN114848614A (zh) | 2013-07-18 | 2022-08-05 | 曼金德公司 | 热稳定性干粉药物组合物和方法 |
CA2920488C (fr) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Appareil d'insufflation et procedes |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
EP3500583A1 (fr) | 2016-08-16 | 2019-06-26 | OPKO Pharmaceuticals, LLC | Disaccharides heptasulfatés purs à biodisponibilité orale améliorée |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE134509T1 (de) * | 1991-06-10 | 1996-03-15 | Schering Corp | Fluorchlorkohlenwasserstoffreie aerosolformulierungen |
WO1993019734A1 (fr) * | 1992-04-02 | 1993-10-14 | Baker Norton Pharmaceuticals, Inc. | Procede et composition de traitement de l'asthme provoque par un antigene et par l'effort |
-
1995
- 1995-08-18 US US08/516,786 patent/US5690910A/en not_active Expired - Fee Related
-
1996
- 1996-08-13 WO PCT/US1996/013133 patent/WO1997006783A1/fr active IP Right Grant
- 1996-08-13 HU HU9901614A patent/HUP9901614A3/hu unknown
- 1996-08-13 JP JP50942897A patent/JP3263723B2/ja not_active Expired - Lifetime
- 1996-08-13 CA CA002229060A patent/CA2229060A1/fr not_active Abandoned
- 1996-08-13 DE DE69635023T patent/DE69635023T2/de not_active Expired - Lifetime
- 1996-08-13 NZ NZ315275A patent/NZ315275A/xx not_active IP Right Cessation
- 1996-08-13 EP EP96926952A patent/EP0844869B1/fr not_active Expired - Lifetime
- 1996-08-13 ES ES96926952T patent/ES2244974T3/es not_active Expired - Lifetime
- 1996-08-13 PL PL96324970A patent/PL186912B1/pl unknown
- 1996-08-13 IL IL12316696A patent/IL123166A/en not_active IP Right Cessation
- 1996-08-13 SK SK172-98A patent/SK282759B6/sk not_active IP Right Cessation
- 1996-08-13 KR KR10-1998-0701167A patent/KR100451901B1/ko not_active IP Right Cessation
- 1996-08-13 CZ CZ1998481A patent/CZ292134B6/cs not_active IP Right Cessation
- 1996-08-13 PT PT96926952T patent/PT844869E/pt unknown
- 1996-08-13 DK DK96926952T patent/DK0844869T3/da active
- 1996-08-13 AU AU66945/96A patent/AU701691B2/en not_active Expired
- 1996-08-13 AT AT96926952T patent/ATE300938T1/de active
- 1996-08-13 UA UA98020876A patent/UA62919C2/uk unknown
- 1996-08-13 ZA ZA9606838A patent/ZA966838B/xx unknown
- 1996-08-15 AR ARP960103997A patent/AR003271A1/es not_active Application Discontinuation
-
1998
- 1998-06-24 HK HK98106409A patent/HK1007060A1/xx not_active IP Right Cessation
-
1999
- 1999-09-23 NZ NZ337996A patent/NZ337996A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUP9901614A2 (hu) | 1999-09-28 |
AR003271A1 (es) | 1998-07-08 |
PL324970A1 (en) | 1998-06-22 |
AU6694596A (en) | 1997-03-12 |
SK17298A3 (en) | 1998-09-09 |
JPH11511196A (ja) | 1999-09-28 |
DE69635023T2 (de) | 2006-05-24 |
SK282759B6 (sk) | 2002-12-03 |
DE69635023D1 (de) | 2005-09-08 |
WO1997006783A1 (fr) | 1997-02-27 |
CA2229060A1 (fr) | 1997-02-27 |
EP0844869A4 (fr) | 2003-04-09 |
UA62919C2 (en) | 2004-01-15 |
ATE300938T1 (de) | 2005-08-15 |
CZ48198A3 (cs) | 1998-11-11 |
NZ337996A (en) | 2001-04-27 |
AU701691B2 (en) | 1999-02-04 |
PT844869E (pt) | 2005-10-31 |
EP0844869A1 (fr) | 1998-06-03 |
JP3263723B2 (ja) | 2002-03-11 |
KR19990037688A (ko) | 1999-05-25 |
PL186912B1 (pl) | 2004-03-31 |
EP0844869B1 (fr) | 2005-08-03 |
US5690910A (en) | 1997-11-25 |
ZA966838B (en) | 1997-02-19 |
MX9801165A (es) | 1998-07-31 |
CZ292134B6 (cs) | 2003-08-13 |
IL123166A0 (en) | 1998-09-24 |
IL123166A (en) | 2002-07-25 |
HUP9901614A3 (en) | 2000-04-28 |
KR100451901B1 (ko) | 2005-09-12 |
ES2244974T3 (es) | 2005-12-16 |
HK1007060A1 (en) | 1999-04-01 |
NZ315275A (en) | 2000-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0844869T3 (da) | ULMWH (heparin med ultralav molekylvægt) til behandling af astma | |
DK0841946T4 (da) | Metoder til behandling af allergisk astma | |
FI951572A0 (fi) | Menetelmä pienmolekyylisten polysakkaridieetterien valmistamiseksi | |
NO983284D0 (no) | Antikoagolante midler egnet i behandling av trombose | |
EE9700113A (et) | Madala molekulmassiga bitsüklilised trombiini inhibiitorid | |
DK1459750T3 (da) | (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser | |
NO923783D0 (no) | Fremgangsmaate for kondensering av naturgass | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
DK0905254T3 (da) | Fremgangsmåde til fremstilling af en lavemolekylær | |
DK0675120T3 (da) | Anvendelse af ascorbyl-gamma-linolenat eller et ascorbyldihomo-gamma-linolenat til behandling af astma, cancer, kardiovaskulære og inflammatoriske lidelser | |
NO911956L (no) | Fremgangsmaate for fremstilling av oxydant sensitive og insensitive, aromatiske estere som inhibitorer for human neutrofil elastase | |
ID19698A (id) | Penyalutan gelas | |
NO20000189L (no) | Fremgangsmõte for fremstilling av heparin | |
EE9900118A (et) | H+,K+-ATPaasi inhibiitorite kasutamine ninapolüüpide ravimisel | |
DE69718808T2 (de) | Plasmabehandlungsmethode | |
DK0737094T3 (da) | Rensning af naturgas. | |
IT1278056B1 (it) | Derivati della s-triazina, loro preparazione e loro impiego come assorbenti uv. | |
FI951541A (fi) | Suurimolekyylipainoinen desulfatohirudiini | |
NO980031D0 (no) | Hvirvelvindturbin med vertikal akse | |
NL1005675A1 (nl) | Polytriazinederivaten-bevattende polyalkylpiperidinyloxy- of polyalkylpiperidinylaminogroepen. | |
NO904533D0 (no) | Fremgangsmaate for molekylvektsregulering av polydiklorfosfasener. | |
NO985325D0 (no) | Anvendelse av substituert azaspiran ved behandling av astma | |
FI935236A0 (fi) | Utan tryck, med hjaelp av vaetska fungerande absorbator foer solfaongare | |
SE9604171D0 (sv) | New modified heparin | |
DE29606219U1 (de) | Inhalationsbrille |